J
Jinling Wang
Researcher at St. Jude Children's Research Hospital
Publications - 10
Citations - 1686
Jinling Wang is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Mutant & Cell cycle. The author has an hindex of 9, co-authored 10 publications receiving 1588 citations.
Papers
More filters
Journal ArticleDOI
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
John R. Jeffers,Evan Parganas,Evan Parganas,Youngsoo Lee,Chunying Yang,Jinling Wang,Jennifer Brennan,Kirsteen H. Maclean,Jia-wen Han,Thomas Chittenden,James N. Ihle,James N. Ihle,Peter J. McKinnon,John L. Cleveland,Gerard P. Zambetti +14 more
TL;DR: It is reported that Puma is essential for hematopoietic cell death triggered by ionizing radiation, deregulated c-Myc expression, and cytokine withdrawal, and required for IR-induced death throughout the developing nervous system and accounts for nearly all of the apoptotic activity attributed to p53 under these conditions.
Journal ArticleDOI
Activation of c-myc Gene Expression by Tumor-Derived p53 Mutants Requires a Discrete C-Terminal Domain
Mark W. Frazier,Xiaoping He,Jinling Wang,Zhengming Gu,John L. Cleveland,John L. Cleveland,Gerard P. Zambetti +6 more
TL;DR: It is suggested that it may be possible to selectively inhibit mutant p53 gain of function and consequently reduce the tumorigenic potential of cancer cells.
Journal ArticleDOI
Regulation of Insulin-like Growth Factor-Mammalian Target of Rapamycin Signaling by MicroRNA in Childhood Adrenocortical Tumors
Mabrouka Doghman,Abeer El Wakil,Bruno Cardinaud,Emilie Thomas,Jinling Wang,Wei Zhao,Maria Helena C. Peralta-Del Valle,Bonald C. Figueiredo,Gerard P. Zambetti,Enzo Lalli +9 more
TL;DR: Results reveal a novel mechanism of regulation of mTOR signaling by miRNAs, and they lay the groundwork for clinical evaluation of drugs inhibiting the mTOR pathway for treatment of adrenocortical cancer.
Journal ArticleDOI
Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
Daniel C. Link,Laura G. Schuettpelz,Dong Shen,Jinling Wang,Matthew J. Walter,Shashikant Kulkarni,Jacqueline E. Payton,Jennifer Ivanovich,Paul J. Goodfellow,Michelle M. Le Beau,Daniel C. Koboldt,David J. Dooling,Robert S. Fulton,R. Hugh F. Bender,Lucinda Fulton,Kimberly D. Delehaunty,Catrina Fronick,Elizabeth L. Appelbaum,Heather Schmidt,Rachel Abbott,Michelle O'Laughlin,Ken Chen,Michael D. McLellan,Nobish Varghese,Rakesh Nagarajan,Sharon Heath,Timothy A. Graubert,Li Ding,Timothy J. Ley,Gerard P. Zambetti,Richard K. Wilson,Elaine R. Mardis +31 more
TL;DR: Whole-genome sequencing can identify novel, cryptic variants in cancer susceptibility genes in addition to providing unbiased information on the spectrum of mutations in a cancer genome.
Journal ArticleDOI
Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways
Frederick W. Quelle,Jinling Wang,Jian Feng,Demin Wang,John L. Cleveland,James N. Ihle,Gerard P. Zambetti +6 more
TL;DR: These findings functionally link the Jak signaling pathway to suppression of p53-mediated cell death by cytokines and demonstrate that the apoptotic and growth arrest responses to DNA damage in hematopoietic cells are modulated by distinct, cytokine specific signal transduction pathways.